Product Images Teriflunomide
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 11 images provide visual information about the product associated with Teriflunomide NDC 62332-313 by Alembic Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Teriflunomide Tablets are manufactured by Alembic Pharmaceuticals Limited and distributed in the USA by Alembic Pharmaceuticals, Inc. They contain 4 mg of teriflunomide per tablet and are typically taken once a day with or without food. This medication guide includes important information for pharmacists to dispense to patients and warns to keep the tablets out of reach of children. The recommended storage temperature is 25°C. The lot number and expiration date are provided, but nothing else is mentioned about the drug's purpose or function.*
This is a medication package for Teriflunomide Tablets containing 30 tablets each with 7 mg of active ingredient. It is manufactured by Alembic Pharmaceuticals Limited and intended for oral use once daily. The tablets can be taken with or without food. The package includes a medication guide for each patient and has a warning to keep out of reach of children. A contact number is provided for inquiries. The location and license number of the manufacturer are also listed. The lot number and expiration date are also shown.*
This appears to be a label for a medication called Teriflunomide Tablets in a package containing 28 tablets. The label includes the drug's National Drug Code (NDC) number, dosage information (per tablet), storage instructions, and a manufacturer's identification code. However, some of the text is incomplete or unclear, and there is no additional information about the drug's usage or potential side effects.*
This is a description of Teriflunomide Tablets, a prescription medication used to treat multiple sclerosis. The tablets are packaged in a bottle with 28 tablets per container. Each tablet contains 7 mg of the active ingredient, teriflunomide. The medication must be stored between 15-30°C. There is a warning on the label to keep the medication out of sight and reach of children. The manufacturer of the medication is not clearly stated in the text.*
This appears to be a table with some statistics related to "14mg vs. Placebo" and "7mg Terffunomide Tablets" for a certain measure as shown by the axes with "0 12 24 3". However, without further context or information about what the measure is, it is difficult to provide a useful description.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.